0.019231 0.000000 0.000000 0.000000 0.017065 0.000000 0.000000 0.000000 0.016155 0.00000 0.00000 0.00000 THERE ARE OXYGENS COVALENTLY BOUND TO SG CYS A 67 AND SG CYS B 67. THEY ARE PRESENTED AS HETATM RECORDS FOLLOWING THE END OF EACH CHAIN. Thanki, N. Wlodawer, A. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 8 90.00 90.00 90.00 52.000 58.600 61.900 C45 H62 N7 O7 1 813.016 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methyl-4-({(1S,2R)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butyl}carbamoyl)hexyl]amino}-2-{[(naphthalen-1-yloxy)acetyl]amino}-3-oxopropyl]-1H-imidazol-3-ium U75875 peptide-like C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O3 S 137.158 n S-HYDROXYCYSTEINE L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking H2 O 18.015 WATER non-polymer C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Protein Sci. PRCIEI 0795 0961-8368 1 1061 1072 1304383 Crystal structure of a complex of HIV-1 protease with a dihydroxyethylene-containing inhibitor: comparisons with molecular modeling. 1992 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 1 x-ray 1 1.0 10805.729 HIV-1 PROTEASE 2 man polymer 813.016 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methyl-4-({(1S,2R)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butyl}carbamoyl)hexyl]amino}-2-{[(naphthalen-1-yloxy)acetyl]amino}-3-oxopropyl]-1H-imidazol-3-ium 1 syn non-polymer 18.015 water 90 nat water no yes PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEI(CSO)GHKAIGTVL VGPTPVNIIGRNLLTQIGCTLNF PQVTLWQRPLVTIKIGGQLKEALLDTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPT PVNIIGRNLLTQIGCTLNF A,B polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n sample 11676 Human immunodeficiency virus 1 562 Escherichia coli 2.10 41.56 pdbx_database_status struct_conf struct_conf_type repository Initial release Version format compliance Atomic model Database references Derived calculations Non-polymer description Structure summary Version format compliance Other Derived calculations Other 1 0 1993-10-31 1 1 2008-03-03 1 2 2011-07-13 1 3 2012-12-12 1 4 2017-11-29 _pdbx_database_status.process_site Y BNL 1992-02-12 REL 1ZK 4-[(2R)-3-{[(1S,2S,3R,4S)-1-(cyclohexylmethyl)-2,3-dihydroxy-5-methyl-4-({(1S,2R)-2-methyl-1-[(pyridin-2-ylmethyl)carbamoyl]butyl}carbamoyl)hexyl]amino}-2-{[(naphthalen-1-yloxy)acetyl]amino}-3-oxopropyl]-1H-imidazol-3-ium HOH water THE SUBCOMPONENT CAV IN INHIBITOR 1ZK IS THE DIPEPTIDE ISOSTERE CYCLOHEXYL ALANINE PSI(CHOH-CHOH)VALINE. THE VALINE HAS A C-OH GROUP IN PLACE OF THE USUAL MAIN CHAIN N ATOM. Inhibitor Noa-His-Cha.psi.[CHOHCHOH]Val-Ile-Amp, U75875 Peptide-like NOA 1 2 1ZK 1ZK 100 A HOH 301 3 HOH HOH 301 A HOH 302 3 HOH HOH 302 A HOH 303 3 HOH HOH 303 A HOH 306 3 HOH HOH 306 A HOH 308 3 HOH HOH 308 A HOH 310 3 HOH HOH 310 A HOH 314 3 HOH HOH 314 A HOH 316 3 HOH HOH 316 A HOH 318 3 HOH HOH 318 A HOH 319 3 HOH HOH 319 A HOH 320 3 HOH HOH 320 A HOH 321 3 HOH HOH 321 A HOH 323 3 HOH HOH 323 A HOH 324 3 HOH HOH 324 A HOH 325 3 HOH HOH 325 A HOH 326 3 HOH HOH 326 A HOH 328 3 HOH HOH 328 A HOH 329 3 HOH HOH 329 A HOH 333 3 HOH HOH 333 A HOH 334 3 HOH HOH 334 A HOH 336 3 HOH HOH 336 A HOH 338 3 HOH HOH 338 A HOH 339 3 HOH HOH 339 A HOH 340 3 HOH HOH 340 A HOH 341 3 HOH HOH 341 A HOH 342 3 HOH HOH 342 A HOH 348 3 HOH HOH 348 A HOH 349 3 HOH HOH 349 A HOH 350 3 HOH HOH 350 A HOH 352 3 HOH HOH 352 A HOH 353 3 HOH HOH 353 A HOH 354 3 HOH HOH 354 A HOH 355 3 HOH HOH 355 A HOH 359 3 HOH HOH 359 A HOH 361 3 HOH HOH 361 A HOH 363 3 HOH HOH 363 A HOH 367 3 HOH HOH 367 A HOH 368 3 HOH HOH 368 A HOH 370 3 HOH HOH 370 A HOH 372 3 HOH HOH 372 A HOH 373 3 HOH HOH 373 A HOH 374 3 HOH HOH 374 A HOH 378 3 HOH HOH 378 A HOH 380 3 HOH HOH 380 A HOH 381 3 HOH HOH 381 A HOH 385 3 HOH HOH 385 A HOH 386 3 HOH HOH 386 A HOH 387 3 HOH HOH 387 A HOH 390 3 HOH HOH 390 A HOH 304 3 HOH HOH 304 B HOH 305 3 HOH HOH 305 B HOH 307 3 HOH HOH 307 B HOH 309 3 HOH HOH 309 B HOH 311 3 HOH HOH 311 B HOH 312 3 HOH HOH 312 B HOH 313 3 HOH HOH 313 B HOH 315 3 HOH HOH 315 B HOH 317 3 HOH HOH 317 B HOH 322 3 HOH HOH 322 B HOH 327 3 HOH HOH 327 B HOH 330 3 HOH HOH 330 B HOH 331 3 HOH HOH 331 B HOH 332 3 HOH HOH 332 B HOH 335 3 HOH HOH 335 B HOH 337 3 HOH HOH 337 B HOH 343 3 HOH HOH 343 B HOH 344 3 HOH HOH 344 B HOH 345 3 HOH HOH 345 B HOH 346 3 HOH HOH 346 B HOH 347 3 HOH HOH 347 B HOH 351 3 HOH HOH 351 B HOH 356 3 HOH HOH 356 B HOH 357 3 HOH HOH 357 B HOH 358 3 HOH HOH 358 B HOH 360 3 HOH HOH 360 B HOH 362 3 HOH HOH 362 B HOH 364 3 HOH HOH 364 B HOH 365 3 HOH HOH 365 B HOH 366 3 HOH HOH 366 B HOH 369 3 HOH HOH 369 B HOH 371 3 HOH HOH 371 B HOH 375 3 HOH HOH 375 B HOH 376 3 HOH HOH 376 B HOH 377 3 HOH HOH 377 B HOH 379 3 HOH HOH 379 B HOH 382 3 HOH HOH 382 B HOH 383 3 HOH HOH 383 B HOH 384 3 HOH HOH 384 B HOH 388 3 HOH HOH 388 B HOH 389 3 HOH HOH 389 B PRO 1 n 1 PRO 1 A GLN 2 n 2 GLN 2 A VAL 3 n 3 VAL 3 A THR 4 n 4 THR 4 A LEU 5 n 5 LEU 5 A TRP 6 n 6 TRP 6 A GLN 7 n 7 GLN 7 A ARG 8 n 8 ARG 8 A PRO 9 n 9 PRO 9 A LEU 10 n 10 LEU 10 A VAL 11 n 11 VAL 11 A THR 12 n 12 THR 12 A ILE 13 n 13 ILE 13 A LYS 14 n 14 LYS 14 A ILE 15 n 15 ILE 15 A GLY 16 n 16 GLY 16 A GLY 17 n 17 GLY 17 A GLN 18 n 18 GLN 18 A LEU 19 n 19 LEU 19 A LYS 20 n 20 LYS 20 A GLU 21 n 21 GLU 21 A ALA 22 n 22 ALA 22 A LEU 23 n 23 LEU 23 A LEU 24 n 24 LEU 24 A ASP 25 n 25 ASP 25 A THR 26 n 26 THR 26 A GLY 27 n 27 GLY 27 A ALA 28 n 28 ALA 28 A ASP 29 n 29 ASP 29 A ASP 30 n 30 ASP 30 A THR 31 n 31 THR 31 A VAL 32 n 32 VAL 32 A LEU 33 n 33 LEU 33 A GLU 34 n 34 GLU 34 A GLU 35 n 35 GLU 35 A MET 36 n 36 MET 36 A SER 37 n 37 SER 37 A LEU 38 n 38 LEU 38 A PRO 39 n 39 PRO 39 A GLY 40 n 40 GLY 40 A ARG 41 n 41 ARG 41 A TRP 42 n 42 TRP 42 A LYS 43 n 43 LYS 43 A PRO 44 n 44 PRO 44 A LYS 45 n 45 LYS 45 A MET 46 n 46 MET 46 A ILE 47 n 47 ILE 47 A GLY 48 n 48 GLY 48 A GLY 49 n 49 GLY 49 A ILE 50 n 50 ILE 50 A GLY 51 n 51 GLY 51 A GLY 52 n 52 GLY 52 A PHE 53 n 53 PHE 53 A ILE 54 n 54 ILE 54 A LYS 55 n 55 LYS 55 A VAL 56 n 56 VAL 56 A ARG 57 n 57 ARG 57 A GLN 58 n 58 GLN 58 A TYR 59 n 59 TYR 59 A ASP 60 n 60 ASP 60 A GLN 61 n 61 GLN 61 A ILE 62 n 62 ILE 62 A LEU 63 n 63 LEU 63 A ILE 64 n 64 ILE 64 A GLU 65 n 65 GLU 65 A ILE 66 n 66 ILE 66 A CSO 67 n 67 CSO 67 A GLY 68 n 68 GLY 68 A HIS 69 n 69 HIS 69 A LYS 70 n 70 LYS 70 A ALA 71 n 71 ALA 71 A ILE 72 n 72 ILE 72 A GLY 73 n 73 GLY 73 A THR 74 n 74 THR 74 A VAL 75 n 75 VAL 75 A LEU 76 n 76 LEU 76 A VAL 77 n 77 VAL 77 A GLY 78 n 78 GLY 78 A PRO 79 n 79 PRO 79 A THR 80 n 80 THR 80 A PRO 81 n 81 PRO 81 A VAL 82 n 82 VAL 82 A ASN 83 n 83 ASN 83 A ILE 84 n 84 ILE 84 A ILE 85 n 85 ILE 85 A GLY 86 n 86 GLY 86 A ARG 87 n 87 ARG 87 A ASN 88 n 88 ASN 88 A LEU 89 n 89 LEU 89 A LEU 90 n 90 LEU 90 A THR 91 n 91 THR 91 A GLN 92 n 92 GLN 92 A ILE 93 n 93 ILE 93 A GLY 94 n 94 GLY 94 A CYS 95 n 95 CYS 95 A THR 96 n 96 THR 96 A LEU 97 n 97 LEU 97 A ASN 98 n 98 ASN 98 A PHE 99 n 99 PHE 99 A PRO 1 n 1 PRO 1 B GLN 2 n 2 GLN 2 B VAL 3 n 3 VAL 3 B THR 4 n 4 THR 4 B LEU 5 n 5 LEU 5 B TRP 6 n 6 TRP 6 B GLN 7 n 7 GLN 7 B ARG 8 n 8 ARG 8 B PRO 9 n 9 PRO 9 B LEU 10 n 10 LEU 10 B VAL 11 n 11 VAL 11 B THR 12 n 12 THR 12 B ILE 13 n 13 ILE 13 B LYS 14 n 14 LYS 14 B ILE 15 n 15 ILE 15 B GLY 16 n 16 GLY 16 B GLY 17 n 17 GLY 17 B GLN 18 n 18 GLN 18 B LEU 19 n 19 LEU 19 B LYS 20 n 20 LYS 20 B GLU 21 n 21 GLU 21 B ALA 22 n 22 ALA 22 B LEU 23 n 23 LEU 23 B LEU 24 n 24 LEU 24 B ASP 25 n 25 ASP 25 B THR 26 n 26 THR 26 B GLY 27 n 27 GLY 27 B ALA 28 n 28 ALA 28 B ASP 29 n 29 ASP 29 B ASP 30 n 30 ASP 30 B THR 31 n 31 THR 31 B VAL 32 n 32 VAL 32 B LEU 33 n 33 LEU 33 B GLU 34 n 34 GLU 34 B GLU 35 n 35 GLU 35 B MET 36 n 36 MET 36 B SER 37 n 37 SER 37 B LEU 38 n 38 LEU 38 B PRO 39 n 39 PRO 39 B GLY 40 n 40 GLY 40 B ARG 41 n 41 ARG 41 B TRP 42 n 42 TRP 42 B LYS 43 n 43 LYS 43 B PRO 44 n 44 PRO 44 B LYS 45 n 45 LYS 45 B MET 46 n 46 MET 46 B ILE 47 n 47 ILE 47 B GLY 48 n 48 GLY 48 B GLY 49 n 49 GLY 49 B ILE 50 n 50 ILE 50 B GLY 51 n 51 GLY 51 B GLY 52 n 52 GLY 52 B PHE 53 n 53 PHE 53 B ILE 54 n 54 ILE 54 B LYS 55 n 55 LYS 55 B VAL 56 n 56 VAL 56 B ARG 57 n 57 ARG 57 B GLN 58 n 58 GLN 58 B TYR 59 n 59 TYR 59 B ASP 60 n 60 ASP 60 B GLN 61 n 61 GLN 61 B ILE 62 n 62 ILE 62 B LEU 63 n 63 LEU 63 B ILE 64 n 64 ILE 64 B GLU 65 n 65 GLU 65 B ILE 66 n 66 ILE 66 B CSO 67 n 67 CSO 67 B GLY 68 n 68 GLY 68 B HIS 69 n 69 HIS 69 B LYS 70 n 70 LYS 70 B ALA 71 n 71 ALA 71 B ILE 72 n 72 ILE 72 B GLY 73 n 73 GLY 73 B THR 74 n 74 THR 74 B VAL 75 n 75 VAL 75 B LEU 76 n 76 LEU 76 B VAL 77 n 77 VAL 77 B GLY 78 n 78 GLY 78 B PRO 79 n 79 PRO 79 B THR 80 n 80 THR 80 B PRO 81 n 81 PRO 81 B VAL 82 n 82 VAL 82 B ASN 83 n 83 ASN 83 B ILE 84 n 84 ILE 84 B ILE 85 n 85 ILE 85 B GLY 86 n 86 GLY 86 B ARG 87 n 87 ARG 87 B ASN 88 n 88 ASN 88 B LEU 89 n 89 LEU 89 B LEU 90 n 90 LEU 90 B THR 91 n 91 THR 91 B GLN 92 n 92 GLN 92 B ILE 93 n 93 ILE 93 B GLY 94 n 94 GLY 94 B CYS 95 n 95 CYS 95 B THR 96 n 96 THR 96 B LEU 97 n 97 LEU 97 B ASN 98 n 98 ASN 98 B PHE 99 n 99 PHE 99 B author_defined_assembly 2 dimeric A CSO 67 S-HYDROXYCYSTEINE A CSO 67 CYS B CSO 67 S-HYDROXYCYSTEINE B CSO 67 CYS 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 4.59 0.50 120.30 124.89 A A A NE CZ NH2 ARG ARG ARG 8 8 8 N 1 9.66 1.60 122.70 132.36 A A A O C N VAL VAL THR 11 11 12 Y 1 -16.87 1.80 110.60 93.73 A A A N CA CB ASP ASP ASP 25 25 25 N 1 8.75 0.90 118.30 127.05 A A A CB CG OD1 ASP ASP ASP 25 25 25 N 1 11.58 0.90 118.30 129.88 A A A CB CG OD1 ASP ASP ASP 29 29 29 N 1 -7.33 0.90 118.30 110.97 A A A CB CG OD2 ASP ASP ASP 29 29 29 N 1 -8.22 0.90 118.30 110.08 A A A CB CG OD2 ASP ASP ASP 30 30 30 N 1 9.63 1.60 122.70 132.33 A A A O C N ASP ASP THR 30 30 31 Y 1 9.78 1.20 123.30 133.08 A A A OE1 CD OE2 GLU GLU GLU 35 35 35 N 1 -13.85 2.00 118.30 104.45 A A A CG CD OE2 GLU GLU GLU 35 35 35 N 1 -4.20 0.50 120.30 116.10 A A A NE CZ NH1 ARG ARG ARG 41 41 41 N 1 4.04 0.50 120.30 124.34 A A A NE CZ NH2 ARG ARG ARG 41 41 41 N 1 15.12 2.00 110.90 126.02 A A A CA CB CG2 ILE ILE ILE 50 50 50 N 1 12.77 1.40 123.60 136.37 A A A CD NE CZ ARG ARG ARG 57 57 57 N 1 -10.52 1.70 111.00 100.48 B B B CB CG CD1 LEU LEU LEU 5 5 5 N 1 7.15 0.90 118.30 125.45 B B B CB CG OD1 ASP ASP ASP 25 25 25 N 1 5.69 0.90 118.30 123.99 B B B CB CG OD1 ASP ASP ASP 29 29 29 N 1 -6.95 0.90 118.30 111.35 B B B CB CG OD2 ASP ASP ASP 29 29 29 N 1 10.17 1.60 122.70 132.87 B B B O C N LEU LEU GLU 33 33 34 Y 1 -13.34 2.00 118.30 104.96 B B B CG CD OE2 GLU GLU GLU 35 35 35 N 1 15.79 1.70 113.30 129.09 B B B CA CB CG MET MET MET 36 36 36 N 1 -12.24 1.70 113.30 101.06 B B B CA CB CG MET MET MET 46 46 46 N 1 -4.37 0.70 120.80 116.43 B B B CB CG CD2 PHE PHE PHE 53 53 53 N 1 8.87 1.20 123.30 132.17 B B B OE1 CD OE2 GLU GLU GLU 65 65 65 N 1 9.68 1.50 110.90 120.58 B B B CA CB CG1 VAL VAL VAL 75 75 75 N 1 11.34 1.60 122.70 134.04 B B B O C N ILE ILE ILE 84 84 85 Y 1 -7.60 1.10 119.40 111.80 B B B NH1 CZ NH2 ARG ARG ARG 87 87 87 N 1 5.21 0.50 120.30 125.51 B B B NE CZ NH2 ARG ARG ARG 87 87 87 N 1 7.32 1.20 111.50 118.82 B B B CB CA C CYS CYS CYS 95 95 95 N 1 A A O O HOH HOH 316 386 2.15 1_555 2_455 1 B PRO 79 -77.93 42.65 0.1690000 2.0 1 2.0 90 1665 59 0 1516 0.020 0.020 0.049 0.035 0.056 0.050 1.475 1.500 2.210 2.000 4.215 3.000 5.934 4.000 0.017 0.020 0.201 0.150 0.191 0.300 0.201 0.300 0.185 0.300 2.8 3.0 17.6 10.0 17.2 20.0 refinement PROLSQ HIV-1 PROTEASE (HIV-1 PR) COMPLEX WITH U75875 (NOA-HIS-CHA-PSI[CH(OH)CH(OH)]VAL-ILE-APY) CRYSTAL STRUCTURE OF A COMPLEX OF HIV-1 PROTEASE WITH A DIHYDROETHYLENE-CONTAINING INHIBITOR: COMPARISONS WITH MOLECULAR MODELING 1 N N 1 N N 2 N N 3 N N 3 N N A GLY 86 A GLY 86 HELX_P A GLY 94 A GLY 94 1 HA 9 B GLY 86 B GLY 86 HELX_P B GLY 94 B GLY 94 1 HB 9 covale 1.330 A ILE 66 A C ILE 66 1_555 A CSO 67 A N CSO 67 1_555 covale 1.302 A CSO 67 A C CSO 67 1_555 A GLY 68 A N GLY 68 1_555 covale 1.329 B ILE 66 B C ILE 66 1_555 B CSO 67 B N CSO 67 1_555 covale 1.288 B CSO 67 B C CSO 67 1_555 B GLY 68 B N GLY 68 1_555 HYDROLASE/HYDROLASE INHIBITOR ACID PROTEINASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX POL_HV1H2 UNP 1 1 P04585 FFREDLAFLQGKAREFSSEQTRANSPTRRELQVWGRDNNSPSEAGADRQGTVSFNFPQVTLWQRPLVTIKIGGQLKEALL DTGADDTVLEEMSLPGRWKPKMIGGIGGFIKVRQYDQILIEICGHKAIGTVLVGPTPVNIIGRNLLTQIGCTLNFPISPI ETVPVKLKPGMDGPKVKQWPLTEEKIKALVEICTEMEKEGKISKIGPENPYNTPVFAIKKKDSTKWRKLVDFRELNKRTQ DFWEVQLGIPHPAGLKKKKSVTVLDVGDAYFSVPLDEDFRKYTAFTIPSINNETPGIRYQYNVLPQGWKGSPAIFQSSMT KILEPFRKQNPDIVIYQYMDDLYVGSDLEIGQHRTKIEELRQHLLRWGLTTPDKKHQKEPPFLWMGYELHPDKWTVQPIV LPEKDSWTVNDIQKLVGKLNWASQIYPGIKVRQLCKLLRGTKALTEVIPLTEEAELELAENREILKEPVHGVYYDPSKDL IAEIQKQGQGQWTYQIYQEPFKNLKTGKYARMRGAHTNDVKQLTEAVQKITTESIVIWGKTPKFKLPIQKETWETWWTEY WQATWIPEWEFVNTPPLVKLWYQLEKEPIVGAETFYVDGAANRETKLGKAGYVTNRGRQKVVTLTDTTNQKTELQAIYLA LQDSGLEVNIVTDSQYALGIIQAQPDQSESELVNQIIEQLIKKEKVYLAWVPAHKGIGGNEQVDKLVSAGIRKVLFLDGI DKAQDEHEKYHSNWRAMASDFNLPPVVAKEIVASCDKCQLKGEAMHGQVDCSPGIWQLDCTHLEGKVILVAVHVASGYIE AEVIPAETGQETAYFLLKLAGRWPVKTIHTDNGSNFTGATVRAACWWAGIKQEFGIPYNPQSQGVVESMNKELKKIIGQV RDQAEHLKTAVQMAVFIHNFKRKGGIGGYSAGERIVDIIATDIQTKELQKQITKIQNFRVYYRDSRNPLWKGPAKLLWKG EGAVVIQDNSDIKVVPRRKAKIIRDYGKQMAGDDCVASRQDED 57 155 1HIV 1 99 P04585 A 1 1 99 57 155 1HIV 1 99 P04585 B 1 1 99 8 8 4 anti-parallel anti-parallel parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel parallel anti-parallel parallel anti-parallel anti-parallel anti-parallel anti-parallel anti-parallel A LYS 43 A LYS 43 A GLY 49 A GLY 49 A GLY 52 A GLY 52 A ILE 66 A ILE 66 A HIS 69 A HIS 69 A GLY 78 A GLY 78 A THR 31 A THR 31 A GLU 34 A GLU 34 A ASN 83 A ASN 83 A ILE 85 A ILE 85 A GLN 18 A GLN 18 A ASP 25 A ASP 25 A PRO 9 A PRO 9 A ILE 15 A ILE 15 A GLU 65 A GLU 65 A ILE 66 A ILE 66 B LYS 43 B LYS 43 B GLY 49 B GLY 49 B GLY 52 B GLY 52 B ILE 66 B ILE 66 B HIS 69 B HIS 69 B GLY 78 B GLY 78 B THR 31 B THR 31 B GLU 34 B GLU 34 B ASN 83 B ASN 83 B ILE 85 B ILE 85 B GLN 18 B GLN 18 B ASP 25 B ASP 25 B PRO 9 B PRO 9 B ILE 15 B ILE 15 B GLU 65 B GLU 65 B ILE 66 B ILE 66 A PRO 1 A PRO 1 A THR 4 A THR 4 B THR 96 B THR 96 B PHE 99 B PHE 99 A THR 96 A THR 96 A PHE 99 A PHE 99 B PRO 1 B PRO 1 B THR 4 B THR 4 BINDING SITE FOR RESIDUE 1ZK A 100 Software 18 A ARG 8 A ARG 8 18 1_555 A ASP 25 A ASP 25 18 1_555 A GLY 27 A GLY 27 18 1_555 A ALA 28 A ALA 28 18 1_555 A ASP 29 A ASP 29 18 1_555 A GLY 48 A GLY 48 18 1_555 A GLY 49 A GLY 49 18 1_555 A ILE 50 A ILE 50 18 1_555 A PRO 81 A PRO 81 18 1_555 A HOH 301 D HOH 18 1_555 A HOH 339 D HOH 18 1_555 B ASP 25 B ASP 25 18 1_555 B GLY 27 B GLY 27 18 1_555 B ALA 28 B ALA 28 18 1_555 B ASP 29 B ASP 29 18 1_555 B GLY 48 B GLY 48 18 1_555 B GLY 49 B GLY 49 18 1_555 B VAL 82 B VAL 82 18 1_555 19 P 21 21 21